Communiqués

05/08 Cardlytics: Q2 Earnings Snapshot AQ
05/08 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance BU
03/08 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BU
03/08 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) AQ
31/07 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BU
29/07 Cardlytics Appoints Chris Cheng as Chief Legal Officer BU
21/07 Cardlytics to Report Second Quarter 2026 Results on August 5 BU
08/05 Cardlytics : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) PU
07/05 Cardlytics: Q1 Earnings Snapshot AQ
07/05 Cardlytics First Quarter 2026 Financial Results Driven By Strong Operational Performance BU
04/05 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) AQ
01/05 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BU
01/05 Cardlytics : CORRECTING and REPLACING Cardlytics Announces Timing of Its First Quarter 2026 Earnings Release PU
27/04 CORRECTING and REPLACING Cardlytics Announces Timing of Its First Quarter 2026 Earnings Release BU
24/03 Cardlytics Completes Sale of Bridg Assets to PAR Technology BU
04/03 Cardlytics: Q4 Earnings Snapshot AQ
04/03 Cardlytics Announces Fourth Quarter and Full Year 2025 Financial Results BU
19/02 Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2025 Earnings Release BU
19/01 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) AQ
16/01 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BU
18/12 Cardlytics Appoints Company Alumnus David Evans as Chief Financial Officer BU
05/11 Cardlytics: Q3 Earnings Snapshot AQ
05/11 Cardlytics Announces Third Quarter 2025 Financial Results BU
22/10/25 Cardlytics Announces Timing of Its Third Quarter 2025 Earnings Release BU
02/10/25 Cardlytics Announces Workforce Reductions As Part Of Organizational Realignment and Cost Savings Initiative BU
Aucun résultat pour cette recherche